Next Green Wave Price Target Increase Justified by Significant Progress During Past Months
Next Green Wave Holdings Inc. (CA: NGW – $0.60 & US: NXGWF – $0.45) is a fully integrated, seed-to-consumer, cannabis company that is licensed for medical and recreational cannabis operations in Coalinga, California. The Company has acquired four medical and recreational Conditional Use Permits (CUP’s) for cultivation, nursery, volatile and non-volatile extraction and distribution.
It is well positioned to capitalize on a massive opportunity after completing a $21 million raise. These proceeds allow the Company to acquire and complete three facilities, finalize the supply chain from seed-to-consumer, and execute its vision to be the world-class nursery and the number one consumer products goods cannabis company in California.
Last month, Next Green Wave also acquired SD Cannabis, a premium cannabis consumer products goods, manufacturing and extraction leader, having 8 leading cannabis brands with 45 CBD and THC products that have a combined global social influencer reach of over 25 million people and with 100+ million YouTube views.
Meanwhile, it launched its first CBD and revenue generating product, Loki Naturals Love Biscuits in cooperation with widely recognized brand partner Loki the Wolfdog. Loki has millions of loyal global social media followers, which is bound to generate a tremendous amount of interest for the biscuits.
The Company is also in the final stages of receiving the certificate of occupancy by the City of Coalinga for its 35,000 sq.ft production facility. Once received, growing operations will be activated.
In addition, NGW made an investment in Organic Medical Growth, a leader in the production and distribution of medical cannabis in Colombia, with a distribution channel of 7,300 pharmacies in the South American country.
We reiterate our buy recommendation for Next Green Wave Holdings with a price target of $1.78, which is 196% above today’s stock price.
Download the second quarter Next Green Wave Company Report.
|Smallcaps Recommendation: Buy||Price Target: $1.78||Latest Company Report (pdf)|
|For important disclosures, please read our disclaimer.|